Covered recipient · General Payments record
JASON R BICKEL
Podiatric Medicine & Surgery Service Providers Podiatrist
General Payments · PY2018–2024
$2,129.78
- Reported across 66 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $495.20 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| MIMEDX Group, Inc. | $164.99 | 6 |
| ORGANOGENESIS INC. | $127.43 | 4 |
| ABBVIE INC. | $120.76 | 3 |
| Stryker Corporation | $27.38 | 1 |
| DePuy Synthes Sales Inc. | $21.87 | 1 |
| Nevro Corp. | $17.78 | 1 |
| Solventum Corporation | $14.99 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $75.20 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103325224 | CMS |
| ABBVIE INC. | $16.59 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103325226 | CMS |
| ABBVIE INC. | $28.97 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103325228 | CMS |
| DePuy Synthes Sales Inc. | $21.87 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077845301 | CMS |
| MIMEDX Group, Inc. | $14.02 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255399 | CMS |
| MIMEDX Group, Inc. | $14.59 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255401 | CMS |
| MIMEDX Group, Inc. | $56.31 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255403 | CMS |
| MIMEDX Group, Inc. | $15.91 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255405 | CMS |
| MIMEDX Group, Inc. | $48.85 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255407 | CMS |
| MIMEDX Group, Inc. | $15.31 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140255409 | CMS |
| Nevro Corp. | $17.78 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130766983 | CMS |
| Organogenesis Inc. | $15.50 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145419669 | CMS |
| Organogenesis Inc. | $21.06 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145419671 | CMS |
| Organogenesis Inc. | $72.43 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145419673 | CMS |
| Organogenesis Inc. | $18.44 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145419675 | CMS |
| Solventum Corporation | $14.99 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144049841 | CMS |
| Stryker Corporation | $27.38 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119777591 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.